Key Points
- CFO Fawwad Qureshi sold 4,645 shares on Feb. 25 at an average price of $25.61 for a total of about $118,958, according to an SEC filing.
- Trupanion reported quarterly EPS of $0.13, missing estimates by $0.01 while revenue rose 11.7% year‑over‑year to $376.85 million, though the company’s net margin remains slim at 1.35%.
- The stock is trading near its 1‑year low (around $25) and carries a consensus analyst rating of "Hold" with an average target price of $45.50 after several recent price‑target cuts.
Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CFO Fawwad Qureshi sold 4,645 shares of the firm's stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $25.61, for a total value of $118,958.45. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Trupanion Stock Performance
NASDAQ TRUP opened at $26.54 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.69 and a quick ratio of 1.69. Trupanion, Inc. has a 1-year low of $25.24 and a 1-year high of $57.88. The business has a 50 day simple moving average of $32.95 and a two-hundred day simple moving average of $38.69. The stock has a market capitalization of $1.15 billion, a PE ratio of 58.98 and a beta of 1.58.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The firm had revenue of $376.85 million for the quarter, compared to analysts' expectations of $375.89 million. During the same period last year, the company earned $0.04 earnings per share. The firm's revenue was up 11.7% on a year-over-year basis. On average, research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
TRUP has been the topic of a number of research reports. Weiss Ratings upgraded shares of Trupanion from a "sell (d+)" rating to a "hold (c-)" rating in a report on Tuesday, February 17th. Wall Street Zen cut Trupanion from a "buy" rating to a "hold" rating in a research note on Saturday, December 6th. Piper Sandler decreased their price objective on Trupanion from $60.00 to $45.00 and set an "overweight" rating on the stock in a research report on Friday, February 13th. Cantor Fitzgerald lowered their price objective on Trupanion from $50.00 to $42.00 and set a "neutral" rating for the company in a research note on Wednesday, January 14th. Finally, Stifel Nicolaus cut their target price on Trupanion from $38.00 to $35.00 and set a "hold" rating on the stock in a research report on Friday, February 13th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $45.50.
View Our Latest Research Report on TRUP
Institutional Investors Weigh In On Trupanion
Hedge funds and other institutional investors have recently modified their holdings of the business. Federated Hermes Inc. purchased a new position in Trupanion during the 3rd quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Trupanion during the third quarter worth $39,000. Nisa Investment Advisors LLC boosted its stake in shares of Trupanion by 44.1% during the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider's stock valued at $54,000 after purchasing an additional 300 shares during the period. Kelleher Financial Advisors purchased a new stake in shares of Trupanion during the third quarter valued at $74,000. Finally, Kemnay Advisory Services Inc. bought a new position in shares of Trupanion in the fourth quarter worth about $64,000.
Trupanion Company Profile
(
Get Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
